Peter Rhode - 22 Jul 2021 Form 4 Insider Report for HCW Biologics Inc. (HCWB)

Role: Title of the Officer: Chief Scientific Officer and Vice President of Clinical Operations.
Signature: /s/ Hing C. Wong, as Attorney-in-Fact for Peter Rhode
Issuer symbol: HCWB
Transactions as of: 22 Jul 2021
Net transactions value: +$100,000
Form type: 4
Filing time: 23 Jul 2021, 19:30:47 UTC
Previous filing: 19 Jul 2021
Next filing: 10 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCWB	Common Stock	Purchase	$100,000	+12,500	+36%	$8.00	46,785	22 Jul 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of Common Stock purchased in connection with the Issuer's initial public offering for consideration of $8.00 per share.

Remarks:

Title of the Officer: Chief Scientific Officer and Vice President of Clinical Operations.